Retour
44
Fourchette du Jour
29,22 €
30,69 €
Fourchette 52 Semaines
8,64 €
38,00 €
Volume
4 058 471
Moyenne 50J / 200J
33,28 €
/
26,76 €
Clôture Précédente
29,30 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 17,5 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 17,0 | 3,9 |
| Rev Growth 5Y % | 11,9 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
43,75 €
+48.9%
Low: 36,00 €
High: 50,00 €
P/E Prévisionnel
9,4
BPA Prévisionnel
3,12 €
Croissance BPA (est.)
+0,0%
CA Est.
1,2 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,15 €
4,01 € – 4,32 €
|
1,4 B | 1 |
| FY2029 |
3,84 €
3,71 € – 4,00 €
|
1,4 B | 1 |
| FY2028 |
3,81 €
3,68 € – 3,97 €
|
1,3 B | 1 |
Points Clés
Revenue grew 11,87% annually over 5 years — strong growth
Earnings grew 10400,00% over the past year
Net margin of 16,95% shows strong profitability
Negative free cash flow of -93,00M
PEG of 0,00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,58%
Croissance
Revenue Growth (5Y)
11,87%
Revenue (1Y)4,29%
Earnings (1Y)10400,00%
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC77,67%
Net Margin16,95%
Op. Margin21,15%
Sécurité
Debt / Equity
N/A
Current Ratio0,71
Interest Coverage5,82
Valorisation
P/E Ratio
17,46
P/B RatioN/A
EV/EBITDA14,59
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,29% | Revenue Growth (3Y) | 6,47% |
| Earnings Growth (1Y) | 10400,00% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11,87% | Earnings Growth (5Y) | 0,60% |
| Profitability | |||
| Revenue (TTM) | 1,24B | Net Income (TTM) | 210,00M |
| ROE | N/A | ROA | 17,44% |
| Gross Margin | 80,23% | Operating Margin | 21,15% |
| Net Margin | 16,95% | Free Cash Flow (TTM) | -93,00M |
| ROIC | 77,67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,71 |
| Interest Coverage | 5,82 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 17,46 | P/B Ratio | N/A |
| P/S Ratio | 2,96 | PEG Ratio | 0,00 |
| EV/EBITDA | 14,59 | Dividend Yield | 0,00% |
| Market Cap | 3,67B | Enterprise Value | 3,82B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,24B | 1,19B | 1,09B | 901,00M | 791,00M |
| Net Income | 210,00M | 2,00M | -129,00M | -44,00M | 205,00M |
| EPS (Diluted) | 1,64 | 0,02 | 0,01 | -0,37 | 1,31 |
| Gross Profit | 994,00M | 957,00M | 919,00M | 750,00M | 664,00M |
| Operating Income | 262,00M | 32,00M | -156,00M | -81,00M | 213,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,20B | 1,32B | 1,77B | 1,78B | 1,83B |
| Total Liabilities | 1,30B | 1,67B | 1,96B | 1,73B | 1,63B |
| Shareholders' Equity | -98,00M | -348,00M | -191,00M | 51,28M | 203,00M |
| Total Debt | 351,00M | 375,00M | 283,00M | 277,00M | 286,00M |
| Cash & Equivalents | 195,00M | 319,00M | 316,00M | 778,18M | 1,10B |
| Current Assets | 652,00M | 839,00M | 1,27B | 1,27B | 1,44B |
| Current Liabilities | 914,00M | 939,00M | 1,29B | 1,02B | 804,00M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#209 of 326
Activité Récente
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026